Intraoperative superficial femoral artery balloon angioplasty and popliteal to distal bypass graft: an option for combined open and endovascular treatment of diabetic gangrene
- PMID: 11331834
- DOI: 10.1067/mva.2001.114210
Intraoperative superficial femoral artery balloon angioplasty and popliteal to distal bypass graft: an option for combined open and endovascular treatment of diabetic gangrene
Abstract
Purpose: The purpose of this study was to evaluate the results of combining intraoperative balloon angioplasty (IBA) of the superficial femoral artery (SFA) with distal bypass graft originating from the popliteal artery as a method of lower extremity revascularization in diabetic patients with gangrene.
Methods: Among 380 infrainguinal bypass grafts performed over a 6-year period, there were 110 reversed saphenous vein bypass grafts to the tibial or pedal arteries to treat diabetic patients with gangrene. Diffuse infrainguinal disease was treated with femoral-distal bypass graft (long; n = 46). Popliteal-distal bypass graft was performed when the inflow femoral artery was not significantly diseased (short; n = 52). Focal SFA stenosis and severe infrageniculate disease were treated with combined IBA of the SFA and distal bypass graft originating from the popliteal artery (combined; n = 12). Follow-up was performed with duplex scan surveillance of both the bypass graft and IBA sites. Treatment groups were compared with life-table analysis.
Results: There were no perioperative graft failures or amputations. The perioperative mortality rate was 1% (1 of 110). The 2-year primary patency rates were similar in the three groups: 72% in the long bypass graft group, 82% in the short bypass graft group, and 76% in the combined group (P =.8, log-rank test). SFA IBA sites developed recurrent stenosis in two patients, at 7 and 48 months; both were detected with surveillance and treated with percutaneous transluminal balloon angioplasty. The overall 5-year rate of primary patency was 63%, secondary patency was 78%, limb salvage was 81%, and survival was 35%. There were no significant differences among the three treatment groups with respect to these outcomes.
Conclusion: Results with the combined procedure were similar to those achieved with either femoral-distal bypass graft or popliteal-distal bypass graft without SFA IBA. These data suggest that IBA of the inflow SFA may be combined with popliteal to distal bypass graft and that this technique is a reasonable alternative to longer, femoral-origin bypass graft in selected diabetic patients with gangrene.
Similar articles
-
Combined percutaneous endovascular iliac angioplasty and infrainguinal surgical revascularization for chronic lower extremity ischemia: preliminary result.Vascular. 2010 Mar-Apr;18(2):71-6. doi: 10.2310/6670.2010.00007. Vascular. 2010. PMID: 20338130
-
Prospective randomized study on reversed saphenous vein infrapopliteal bypass to treat limb-threatening ischemia: common femoral artery versus superficial femoral or popliteal and tibial arteries as inflow.J Vasc Surg. 2004 Oct;40(4):732-40. doi: 10.1016/j.jvs.2004.07.023. J Vasc Surg. 2004. PMID: 15472602 Clinical Trial.
-
[Factors determining late patency of aortobifemoral bypass graft].Srp Arh Celok Lek. 1997 Jan-Feb;125(1-2):24-35. Srp Arh Celok Lek. 1997. PMID: 17974352 Serbian.
-
Femorofemoral bypass graft: analysis of patency and factors influencing long-term outcome.J Vasc Surg. 1993 Sep;18(3):495-504; discussion 504-5. J Vasc Surg. 1993. PMID: 8377244 Review.
-
Challenges of distal bypass surgery in patients with diabetes: patient selection, techniques, and outcomes.J Vasc Surg. 2010 Sep;52(3 Suppl):96S-103S. doi: 10.1016/j.jvs.2010.06.015. J Vasc Surg. 2010. PMID: 20804940 Review.
Cited by
-
Global vascular guidelines on the management of chronic limb-threatening ischemia.J Vasc Surg. 2019 Jun;69(6S):3S-125S.e40. doi: 10.1016/j.jvs.2019.02.016. Epub 2019 May 28. J Vasc Surg. 2019. PMID: 31159978 Free PMC article.
-
Outcomes of Popliteal-To-Distal Bypass Combined with Femoropopliteal Artery Endovascular Treatment for Critical Limb Ischemia.Ann Vasc Dis. 2017 Sep 25;10(3):223-8. doi: 10.3400/avd.oa.17-00049. Ann Vasc Dis. 2017. PMID: 29147165 Free PMC article.
-
Global Vascular Guidelines on the Management of Chronic Limb-Threatening Ischemia.Eur J Vasc Endovasc Surg. 2019 Jul;58(1S):S1-S109.e33. doi: 10.1016/j.ejvs.2019.05.006. Epub 2019 Jun 8. Eur J Vasc Endovasc Surg. 2019. PMID: 31182334 Free PMC article.
-
Hybrid endarterectomy and endovascular therapy in multilevel lower extremity arterial disease involving the femoral artery bifurcation.Int Surg. 2012 Jan-Mar;97(1):56-64. doi: 10.9738/0020-8868-97.1.56. Int Surg. 2012. PMID: 23102001 Free PMC article.
-
Bergapten exerts inhibitory effects on diabetes-related osteoporosis via the regulation of the PI3K/AKT, JNK/MAPK and NF-κB signaling pathways in osteoprotegerin knockout mice.Int J Mol Med. 2016 Dec;38(6):1661-1672. doi: 10.3892/ijmm.2016.2794. Epub 2016 Nov 2. Int J Mol Med. 2016. PMID: 27840967 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical